178 filings
Page 6 of 9
8-K
fv1qdop0dri0n1fjh7
5 Jan 18
Entry into a Material Definitive Agreement
12:00am
8-K
jc47nnw0zd2231qyobwr
28 Dec 17
Other Events
12:00am
8-K
pze0id5mhej
1 Dec 17
Intercept Pharmaceuticals Appoints Christian Weyer as Executive Vice President of Research & Development
12:00am
8-K
zd6zac
7 Nov 17
Departure of Directors or Certain Officers
12:00am
8-K
xx058tu
1 Nov 17
Intercept Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update
12:00am
8-K
a0ip rxduilfl
31 Jul 17
Intercept Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Business Update
12:00am
8-K
0jfd68ubpibii 58
30 Jun 17
Submission of Matters to a Vote of Security Holders
12:00am
8-K
niq30ypc7
4 May 17
Intercept Pharmaceuticals Reports First Quarter 2017 Financial Results and Provides Business Update
12:00am
8-K
2q84nw hi
23 Feb 17
Intercept Pharmaceuticals Reports Full Year 2016 Financial Results and Provides Business Update
12:00am
8-K
umfbn0s3l ynfrqyg
9 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
614wgh5j
3 Nov 16
Intercept Pharmaceuticals Reports Third Quarter 2016 Financial Results and Provides Business Update
12:00am
8-K
vxi358fdjwlp
13 Oct 16
Departure of Directors or Certain Officers
12:00am
8-K
hj471 oit
12 Sep 16
Other Events
12:00am
8-K
570jv50j dsea7d
18 Aug 16
Entry into a Material Definitive Agreement
12:00am
8-K
cy9325 fr
4 Aug 16
Intercept Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Business Update
12:00am
8-K
ud9mt73
22 Jul 16
Entry into a Material Definitive Agreement
12:00am
8-K
kvpe 5zno3
11 Jul 16
Departure of Directors or Certain Officers
12:00am
8-K
w94l0hgk7v
6 Jul 16
Intercept Pharmaceuticals Announces Pricing of Public Offering of Convertible Senior Notes
12:00am
8-K
hlc bkhe20w5
28 Jun 16
Departure of Directors or Certain Officers
12:00am
8-K
eyro48v 7m1kf6
10 Jun 16
Intercept Pharmaceuticals Appoints Sandip Kapadia as Chief Financial Officer
12:00am